CVS Health Corporation
CVS Healthcare Healthcare Plans
CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024.
- Revenue
- +5.37%
- EPS
- +154.1%
- Free cash flow
- +3,886.7%
- Total debt
- −7.83%
Quarter to September 2026, against a year earlier
Follow CVS
Alert me
CVS Health Corporation (CVS) P/E ratio
As of 6 November 2026, CVS Health Corporation (CVS) trades at a P/E ratio of 9.6×. Over the past ten years it has ranged from 0.0× (June 2019) to 208× (October 2025); the current reading is higher than 6% of that period. That is below the Healthcare Plans industry median of 22.5× and below the Healthcare sector median of 24.5×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 56.3× | 360.15% |
| FY2024 | 12.2× | (1.81%) |
| FY2023 | 12.5× | (57.50%) |
| FY2022 | 29.3× | 70.47% |
| FY2021 | 17.2× | 37.95% |
| FY2020 | 12.5× | (14.61%) |
| FY2019 | 14.6× | — |
| FY2018 | 0.0× | — |
| FY2017 | 11.3× | (30.25%) |
| FY2016 | 16.3× | (22.31%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 9.9× | (63.34%) |
| Jun 2026 | 27.0× | (13.12%) |
| Mar 2026 | 31.1× | (44.76%) |
| Dec 2025 | 56.3× | (70.14%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MOH Molina Healthcare, Inc compare | n/m |
| CVS CVS Health Corporation | 9.6× |
| OSCR Oscar Health, Inc. compare | 11.0× |
| CI Cigna Group compare | 12.9× |
| ELV Elevance Health, Inc. compare | 18.2× |
| UNH UnitedHealth Group Incorporated compare | 22.5× |
| CNC Centene Corporation compare | 23.5× |
| PGNY Progyny, Inc. compare | 30.1× |
| HUM Humana Inc. compare | 41.9× |
| Healthcare Plans industry median | 22.5× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on CVS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement